# Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia

> **NCT02199327** · PHASE4 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 18 (actual)

## Conditions studied

- Conjunctival Intraepithelial Neoplasia
- Corneal Intraepithelial Neoplasia

## Interventions

- **DRUG:** Mitomycin C
- **DRUG:** Interferon Alfa-2b

## Key facts

- **NCT ID:** NCT02199327
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-12-16
- **Final completion:** 2017-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199327, "Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02199327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*